Works matching IS 09255710 AND DT 2011 AND VI 93 AND IP 5


Results: 19
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia.

    Published in:
    2011
    By:
    • Yoshida, Chikashi;
    • Komeno, Takuya;
    • Hori, Mitsuo;
    • Kimura, Tomofumi;
    • Fujii, Masami;
    • Okoshi, Yasushi;
    • Suzukawa, Kazumi;
    • Chiba, Shigeru;
    • Hasegawa, Yuichi;
    • Mukai, Harumi;
    • Ito, Takayoshi;
    • Shimizu, Seiichi;
    • Kamoshita, Masaharu;
    • Kudo, Daisuke;
    • Shinagawa, Atsushi;
    • Chikatsu, Norio;
    • Monma, Yuriko;
    • Watanabe, Norimichi;
    • Kojima, Hiroshi;
    • Mukai, Harumi Yamamoto
    Publication type:
    journal article
    18